April 7, 2022 -- Life sciences company Mission Bio has announced the appointment of Dr. Todd Druley, PhD, as chief medical officer (CMO), a newly created role at Mission Bio.
Druley brings to the role his vast experience in molecular diagnostics and building clinical programs, the company said in a press release. Prior to joining Mission Bio, Druley held CMO roles at Angle Biosciences and ArcherDX. He is also currently a scientific advisor for RhoDx.
Since 2016, he has also worked with Mission Bio's Tapestry Platform, the company's multiomics platform that can analyze DNA and protein simultaneously from the same sample at single-cell resolution.